论文部分内容阅读
奈必洛尔在德国上市一日1次的β受体阻滞剂奈必洛尔（nebivolol，商品名Nebilet）已由Menarini公司首次在德国上市，用于原发性高血压的治疗。奈必洛尔30×5mg片剂定价为53．58德国马克。奈必洛尔对高血压具有血管扩张和心脏保护双重作用机制，因而它是作为一种较好的双效阻滞
Nebivolol, a beta blocker once a day in Germany, has been first introduced by Menarini in Germany as a nebivolol for the treatment of essential hypertension. Nebivolol 30x5mg tablets are priced at 53.58 DM. Nebivolol has a dual mechanism of action of vasodilation and cardioprotection on hypertension, so it is better as a dual-effect block